Sanofi SNY
NASDAQ SNY
$42.72 -0.13 (-0.30%)
As of: Sep 10, 2026 · 3:59 PM EDT

Sanofi (SNY) Assets Average (2018 - 2026)

Sanofi's (SNY) quarterly Assets Average came in at $149.9 billion in Q2 2026, up 7.04% year-over-year from $140.1 billion in Q2 2025, and up 0.81% quarter-over-quarter from $148.7 billion in Q1 2026.

Analysis

Sanofi (SNY) Assets Average (2018 - 2026) Analysis & Trends

Sanofi has disclosed Assets Average across 3 years of filings, most recently posting $149.9 billion for Q2 2026.

  • In Q2 2026, Assets Average rose 7.04% year-over-year to $149.9 billion; the TTM figure through Jun 2026 stood at $149.9 billion (up 7.04% YoY), while the FY2024 annual figure was $140.3 billion, up 3.76% from the prior year.
  • Assets Average came in at $149.9 billion for Q2 2026 at Sanofi, up from $148.7 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $149.9 billion in Q2 2026 to a low of $140.1 billion in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 200.98 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 135.79 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 129.24 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 120.28 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 204.57 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 149.95 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 3.29 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 7.61 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 6.97 Bn
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn 5.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 149.95 Bn
Mar 31, 2026 148.75 Bn
Dec 31, 2025 149.67 Bn
Sep 30, 2025 146.59 Bn
Jun 30, 2025 140.09 Bn
Mar 31, 2025 140.32 Bn
Dec 31, 2018 64.51 Bn
Sep 30, 2018 68.22 Bn
Jun 30, 2018 135.89 Bn
Mar 31, 2018 127.35 Bn